Mukadam

Dr. Lalpathlabs thrust towards 3997

Long
Mukadam Updated   
NSE:LALPATHLAB   DR LAL PATHLABS LTD
Targets 3478 and 3997 as the 3rd Wave arrives

Good Fundamentals:
High Management Efficiency with a high ROE of 22.80%
Company has a low Debt to Equity ratio (avg) at -0.79 times
With a growth in Net Profit of 161.04%, the company declared Very Positive results in Mar 21
The company has declared positive results for the last 2 consecutive quartersPBT LESS OI(Q) At Rs 97.30 cr has Grown at 191.32 %PAT(Q) At Rs 83.40 cr has Grown at 156.6 %ROCE(HY) Highest at 32.96 %
High Institutional Holdings at 33.53%
These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Trade closed: target reached:
Idea closed at 4000 after achieving 2nd target with profit of 18%
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.